How much do condoms cut STI risk? The numbers, infection by infection

Condoms reduce the risk of every sexually transmitted infection that has been studied, but by very different amounts depending on how the infection spreads. Used consistently, they cut HIV transmission by about 80% [s1] and sharply reduce genital HPV infection [s2], yet offer only about 30% protection against genital herpes [s3].

The reason for that spread is mechanical. A condom blocks the genital fluids that carry infections such as HIV, gonorrhoea and chlamydia, but it covers only part of the skin, so infections spread by skin-to-skin contact of areas it leaves exposed — herpes, HPV, syphilis — slip past it more often [s4]. That single fact explains most of the numbers below.

HIV: about 80%

The strongest evidence concerns HIV. A Cochrane review pooled cohort studies of HIV-serodiscordant heterosexual couples — one partner infected, one not — and compared infection rates between couples who always used condoms and couples who never did [s1]. Among consistent users, HIV incidence was 1.14 per 100 person-years; among never-users in the longest-followed studies it was 5.75 per 100 person-years [s1]. The review's headline estimate is that consistent condom use produces roughly an 80% reduction in HIV incidence [s1].

The word consistent matters. The reduction reflects using a condom for every act of penetrative intercourse; it is an estimate of real-world effectiveness, not of a condom's theoretical efficacy when used perfectly every time, which the studies could not measure [s1].

HPV: a large reduction, not a guarantee

Genital HPV spreads by skin contact, so condoms were long assumed to do little against it. A prospective study that followed 82 women from their first intercourse found otherwise. Genital HPV incidence was 37.8 per 100 patient-years among women whose partners used condoms every time, against 89.3 per 100 patient-years when partners used them less than 5% of the time — an adjusted hazard ratio of 0.3 (95% CI 0.1-0.6) [s2]. Among women reporting 100% condom use, no cervical precancerous lesions were detected across 32 patient-years of follow-up, while 14 lesions appeared among women whose partners used condoms less consistently [s2].

So condoms substantially reduce HPV transmission, but the residual risk is real, which is why they are treated as a complement to — not a substitute for — HPV vaccination.

Herpes: moderate protection

Herpes sits at the harder end of the spectrum. A pooled analysis of six prospective studies — the largest such effort using prospective data — covered 5,384 people who were HSV-2-negative at baseline and contributed more than 2 million days of follow-up, 415 of whom acquired the virus [s3]. Consistent condom users had a 30% lower risk of HSV-2 acquisition than never-users (hazard ratio 0.70, 95% CI 0.40-0.94) [s3]. Risk rose steadily with each unprotected sex act (hazard ratio 1.16 per act), and the protective effect did not differ between men and women [s3]. The authors described the protection as moderate — real, but smaller than for infections carried in fluids, exactly as the skin-contact mechanism predicts [s3].

Gonorrhoea and chlamydia sit at the easier end. Both are carried in genital secretions rather than transmitted by skin contact, so a condom that stays intact blocks the route of transmission directly, and public-health guidance treats consistent condom use as an effective way to reduce the risk of both [s4]. Syphilis, whose sores can appear on skin a condom does not cover, is closer to herpes: condoms reduce but do not eliminate the risk [s4].

What the numbers mean, and don't

Three cautions travel with all of these figures. First, they measure consistent use; typical use is less consistent, and condoms can slip or break, so real-world protection is lower than the best-case numbers [s1]. Second, protection is partial for every infection and negligible for syphilis or herpes lesions on skin a condom does not cover [s4]. Third, condoms guard against infection and pregnancy at once — their contraceptive failure rate under typical use is a separate calculation from their effect on infection.

None of that argues against condoms; it argues for pairing them with the other tools whose evidence the site covers — routine STI screening, vaccination, and, for some couples, the newer contraceptive and prevention options now in development. Consistently used, the condom remains the single barrier method with proven effect against the widest range of sexually transmitted infections [s4].